Introducing BBI’s Morffi™ signal enhancement technology: An evolution in assay performance.
What is Morffi?
Morffi is a novel conjugation blocking technology, developed in-house by BBI scientists. It provides an increase in sensitivity and improves assay performance when compared to existing gold conjugation methods.
Morffi is offered as part of BBI’s lateral flow development service. By working with BBI you can deliver truly next generation performance into the hands of your customers with:
- Up to 10x more sensitivity
- Improved signal intensity
- Faster time to results
How does it work?
Morffi is patent pending, BBI know-how and the specifics about the technology are protected. However, we are able to tell you that it works by increasing the availability of the binding partner on the label surface, thereby increasing the opportunity for binding between the binding partner and the target analyte.
Due to the simplicity of the technology, it can be easily integrated into an existing test without the need for complicated redevelopment. A simple feasibility study would need to be done on your existing test, or a proof-of-principle if you are considering Morffi for use with a brand-new test.
As well as increased speed and sensitivity, other benefits include:
- BSA (Bovine Serum Albumin) free conjugates, which eradicate the potential for cross contamination with human serum albumin-binding antibodies or when aiming to detect bovine-origin or non-bovine animal targets.
- Simple, fast and inexpensive development as there is no need to change assay format or materials.
- The excellent stability of this lateral flow conjugation process, so your product will have a long shelf life.
Why choose BBI’s Morffi technology?
Choosing Morffi will eradicate the need to use the BSA in assay conjugates and in doing so will eliminate issues with cross-reactivity. It can also help gain competitive advantage by extending the life of your assay, to achieve a higher level of performance.
BBI’s manufacturing facilities, can accommodate scale-up which will allow fast entry into established markets.
Want to know more?
We’ve tested our innovation on over 30 conjugates to-date and are confident that our results show increased performance. Follow the quick links below to find out more:
Register your interest by completing our online form.
Or book a meeting with one of our team at Medica 2016 to find out more.